STADA Arzneimittel AG (STAGn.DE)
15 Dec 2017
FRANKFURT Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulatory concerns about side effects having frustrated its ambitions almost seven years ago.
* Unit head Garijo says targeting most severely affected patients
LONDON/FRANKFURT Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.
* Perrigo to submit non-binding offer for Merck KGaA's OTC unit
LONDON/FRANKFURT, Dec 14 U.S. drugmaker Perrigo has decided to enter the fray for Merck KgaA's consumer health unit, sources told Reuters on Thursday, and is preparing an indicative offer for the $4.7 billion business ahead of the Dec. 15 deadline.
ZURICH, Dec 4 The Swiss blue-chip SMI was seen opening 1 percent higher at 9,365 points on Monday, according to premarket indications by bank Julius Baer .
FRANKFURT, Dec 4 The following are some of the factors that may move German stocks on Monday:
Dec 1 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday:
LONDON/FRANKFURT Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's consumer health unit, several sources told Reuters.
* CEO says are confident that a profit and domination agreement with Elliott can be concluded at an EGM in Q1 2018 Further company coverage: